Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03946358
Title	Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL) (VolATIL)
Acronym	VolATIL
Recruitment	Active, not recruiting
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Centre Hospitalier Universitaire de Besancon
Indications	vulva squamous cell carcinoma anal squamous cell carcinoma cervical squamous cell carcinoma head and neck squamous cell carcinoma
Therapies	Atezolizumab + UCPVax
Age Groups:	adult \| senior
Covered Countries	FRA